UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019977
Receipt number R000023066
Scientific Title Efficacy and safety of orexin receptor antagonist as premedication
Date of disclosure of the study information 2015/11/30
Last modified on 2015/12/07 19:15:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and safety of orexin receptor antagonist as premedication

Acronym

Orexin receptor antagonist premedication

Scientific Title

Efficacy and safety of orexin receptor antagonist as premedication

Scientific Title:Acronym

Orexin receptor antagonist premedication

Region

Japan


Condition

Condition

Patients who underwent surgery under general anesthesia

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Many sleeping pills is adaptive as premedication, have been used.
There is no report of use experience as a premedication of orexin receptor antagonists Belsomra ®.
In this study, it was administered Belsomra ® as a pre-medication, to consider the effect.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood pressure, Herat rate, Pulse oximetry, Ramsey sedation score:RSS

Key secondary outcomes

visual analog scale
postoperative nause and vomiting
Patient satisfaction
Safety of transport


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Patient receive oral belsomra premedication before induction anesthesia.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients, ASA physical state of I-III, undergoing surgery with general anesthesia
.

Key exclusion criteria

over ASA physical state of IV
pregnancy
patients under twenty year old
Patient consent can not be obtained

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Nami Kakuta

Organization

Institute of Biomedical Sciences Tokushima University Graduate School

Division name

Department of Anesthesiology

Zip code


Address

770-8503

TEL

81-88-633-7181

Email

kakuta.nami@tokushima-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Nami Kakuta

Organization

Institute of Biomedical Sciences Tokushima University Graduate School

Division name

Department of Anesthesiology

Zip code


Address

770-8503

TEL

81-88-633-7181

Homepage URL


Email

kakuta.nami@tokushima-u.ac.jp


Sponsor or person

Institute

Institute of Biomedical Sciences Tokushima University Graduate School
Department of Anesthesiology

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 11 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2015 Year 11 Month 30 Day

Date of IRB


Anticipated trial start date

2016 Year 01 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 11 Month 28 Day

Last modified on

2015 Year 12 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023066


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name